BV insider plans sale of 62,619 shares via Morgan Stanley — $912K value
Rhea-AI Filing Summary
BrightView Holdings, Inc. (BV) filed a Form 144 notifying the proposed sale of 62,619 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $912,095.83. The filing shows approximately 94,900,000 shares outstanding, so the proposed sale represents a small fraction of total shares. The shares listed were acquired primarily through restricted stock vesting under a registered plan on various dates from 2021 through 2024. The filer also reported a sale of 14,800 shares on 08/25/2025 generating $218,004.51 in gross proceeds.
Positive
- None.
Negative
- None.
Insights
TL;DR: A company insider plans a modest sale of vested restricted shares, representing a negligible portion of outstanding stock.
The Form 144 discloses a proposed sale of 62,619 shares valued at about $912k against ~94.9M shares outstanding, implying the sale is immaterial to BrightView's market capitalization and unlikely to materially affect share supply or valuation. The shares originate from routine restricted stock vesting events spanning 2021–2024, indicating compensation-related liquidity rather than a change in company fundamentals. The recent sale of 14,800 shares for $218k confirms some near-term liquidation activity, but amounts remain small relative to company size.
TL;DR: Proper Rule 144 disclosure of planned insider sale; no red flags in acquisition history or payment terms.
The filing documents compliance with Rule 144 requirements and includes detailed acquisition dates and that payment was Not Applicable (shares vested). Multiple entries show restricted stock vesting under a registered plan, which is a common compensation mechanism. There is an explicit signer representation regarding absence of undisclosed material adverse information. From a governance perspective, this appears to be routine insider monetization rather than a governance concern.